Antisense Oligonucleotides Market

Future Market Insights

Key Insight

The antisense oligonucleotides market is projected to grow from USD 3.3 billion in 2025 to USD 6.1 billion by 2035, at a CAGR of 6.3%. Pegaptanib will dominate with a 35.0% market share, while ocular diseases will lead the indication segment with a 30.0% share.

September 25, 2025

Anurag Sharma

321 Pages

Cite this Report

Antisense Oligonucleotides Market

https://www.futuremarketinsights.com/reports/antisense-oligonucleotides-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Antisense Therapeutics Limited
Bio-Path Holdings
Geron Corporation
GSK
Isarna Therapeutics GmbH
OncoGenex Pharmaceuticals Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Antisense Oligonucleotides Market

Key Players

Similar Industry Reports